Ascendis Pharma AS
ASND · NASDAQ131.35
131.35
USD-2.32-1.74%Balance Sheet
Total Assets
22.82M
25.41M
26.7M
Liabilities And Stockholders Equity
22.82M
25.41M
26.7M
Income Statement
Total Revenue
-
15.58M
20.41M
Cost Of Revenue
-
-
-
Gross Profit
-
15.58M
20.41M
Total Operating Expenses
-
14.07M
15.13M
Operating Income
-
1.51M
5.28M
Income Before Tax
-
1.28M
4.71M
Net Income After Taxes
-
-
-
Net Income Before Extraordinary Items
-
-
-
Net Income
-
1.25M
4.08M
Net Income Applicable To Common Shares
-
-
4.08M
Diluted Net Income
-
-
4.08M
Diluted Weighted Average Shares
-
-
-
Diluted EPS Excluding Extraordinary Items
-
-
-
Diluted Normalized EPS
-
-
-
EBIT
-
1.51M
5.28M
Cash Flow
Total Cash From Operating Activities
-
-652K
6.31M
Total Cash Flows From Investing Activities
-
-
-1.2M
Total Cash From Financing Activities
-
-205K
-220K
Exchange Rate Changes
-
-
-
Change In Cash
-
-1.15M
4.89M
Free Cash Flow
-
-943K
5.12M
What are you waiting for?Start making profit today
©
2024
All rights reserved
Cart